At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 300 enrolled
Drug / intervention
PICOPREP +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-center, Randomized, Single-blind Clinical Study of the Efficacy and Safety of PICOPREP and Polyethylene Glycol-electrolyte 4000 Powder for Oral Solution (PEG-ELS) for the Bowel Preparation Prior Colonoscopy
In Brief
A Phase 3 clinical trial evaluating PICOPREP and PEG-ELS for Colonoscopy. Completed, enrolled 300 participants across 7 sites.
Detailed Summary
Eligible subjects undergoing a colonoscopy will randomly receive either PICOPREP or polyethylene glycol 4000 electrolyte lavage solution before the procedure to evaluate its effectiveness, tolerability and safety.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsColonoscopy
CountriesChina
Collaborators--
Timeline
Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
Primary CompletionMay 2011
First PostedMay 2011
Study CompletionJul 2011
TodayJul 2026
First PostedMay 19, 2011
Enrollment StartJan 1, 2011
Primary CompletionMay 1, 2011
Study CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 15.1 years ago
Interventions
PICOPREPdrug
PEG-ELSdrug